Catalent cuts 150 leadership, support jobs in Bloomington

New Jersey-based Catalent Inc. is a contract drug manufacturer that significantly increased its operations at the Monroe County location during the pandemic to meet the demand for COVID-19 vaccines. It's that same plant that the company blames in part for productivity issues and unexpected costs.... Read More

VisionTech invests in Arizona biotech company

Indianapolis-based VisionTech Angels has invested nearly $200,000 in NuvOx Pharma, a clinical stage biotechnology company in Tuscon, Arizona. NuvOx is developing what it calls a first-in-class oxygen therapeutic to treat life-threatening diseases.... Read More

Inotiv posts Q2 loss; facility consolidations continue

West Lafayette-based Inotiv Inc. is reporting a fiscal second quarter net loss of $10 million, compared to a loss of $6.1 million during the same period last year. Despite the loss, CEO Robert Leasure said the company is making progress with its ongoing site optimization initiatives.... Read More

Bloomington operation part of $4.2B divestiture

Illinois-based Baxter International Inc. this week announced plans divest its BioPharma Solutions business to Advent International and Warburg Pincus, private equity firms headquartered in Boston and New York, respectively, in a $4.25 billion deal. ... Read More

Northwind Pharma acquires Oregon company

Indianapolis-based Northwind Pharmaceuticals LLC has acquired QVI Risk Solutions, a health benefit administrator headquartered in Bend, Oregon. The private pharmaceutical repackaging company did not disclose financial details of the deal.... Read More

Purdue receives $100M for Pluvicto royalties

The Purdue Research Foundation said Wednesday it has received more than $100 million from Owl Rock in New York for a portion of its royalty interest in the prostate cancer drug Pluvicto. Purdue plans to use the funding to further support research at the university.... Read More